Carr Financial Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,367
Closed -$405K 194
2025
Q4
$405K Hold
8,367
0.11% 120
2025
Q3
$395K Hold
8,367
0.11% 120
2025
Q2
$404K Hold
8,367
0.12% 114
2025
Q1
$464K Sell
8,367
-1,908
-19% -$103K 0.15% 98
2024
Q4
$496K Sell
10,275
-398
-4% -$20.2K 0.15% 97
2024
Q3
$615K Hold
10,673
0.18% 92
2024
Q2
$518K Hold
10,673
0.16% 102
2024
Q1
$519K Hold
10,673
0.17% 101
2023
Q4
$531K Hold
10,673
0.2% 84
2023
Q3
$489K Sell
10,673
-50
-0.5% -$2.67K 0.19% 90
2023
Q2
$578K Sell
10,723
-650
-6% -$35K 0.23% 80
2023
Q1
$619K Hold
11,373
0.27% 75
2022
Q4
$551K Buy
+11,373
New +$499K 0.29% 75

Other funds holding SNY

Carr Financial Group's SNY Position: Q1 2026 in Review

Carr Financial Group sold out of Sanofi (SNY) in Q1 2026, closing a stake of 8,367 shares — an estimated $405K sold.

Carr Financial Group first reported a position in SNY in Q4 2022 and held it in 13 quarters. The position peaked at $619K in Q1 2023. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Carr Financial Group reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Carr Financial Group sold 8,367 Sanofi shares in Q1 2026, an estimated $405K.
  • Carr Financial Group first reported a position in Sanofi in Q4 2022 and held it in 13 quarters.
  • Carr Financial Group's Sanofi position peaked at $619K in Q1 2023.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.